Learn about Dural Venous Sinus Thrombosis (DVST), also known as Cerebral Venous Sinus Thrombosis or Intracranial Venous Thrombosis. This resource provides information on diagnosis, clinical documentation, and medical coding for DVST, including ICD-10 codes and healthcare best practices for managing this condition. Find essential details for accurate clinical documentation and appropriate medical coding of Dural Venous Sinus Thrombosis.
Also known as
Cerebral venous sinus thrombosis
Blockage of venous sinuses in the brain.
Other cerebral venous thrombosis
Thrombosis in cerebral veins, not sinuses.
Other disorders of brain
Includes various brain disorders like venous thrombosis.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the thrombosis in a dural venous sinus?
When to use each related code
| Description |
|---|
| Blood clot in brain's venous sinuses. |
| Blood clot in brain's veins or venules. |
| Blood clot in cavernous sinus. |
Coding to the nonspecific 'intracranial thrombosis' (I63.6) instead of the more specific Dural Venous Sinus Thrombosis (I63.1).
Missing documentation of laterality (right, left, bilateral) which impacts accurate coding and reimbursement.
Failure to capture and code any underlying conditions (e.g., pregnancy, malignancy) contributing to the thrombosis.
Q: What are the key differentiating features in the diagnosis of dural venous sinus thrombosis (DVST) versus other headache etiologies like migraine or tension-type headache in a neurology setting?
A: Differentiating dural venous sinus thrombosis (DVST) from other headache etiologies like migraine or tension-type headache requires careful consideration of clinical presentation, risk factors, and neuroimaging. While headache is a common symptom in all three, DVST headaches are often described as progressive, worsening over days or weeks, and may be accompanied by focal neurological deficits, seizures, papilledema, or visual disturbances. Migraines and tension headaches typically have distinct characteristics such as pulsating quality (migraine), associated nausea/vomiting or photo/phonophobia (migraine), and band-like tightness (tension headache). A thorough patient history, including recent infections, pregnancy/postpartum status, coagulopathies, and medication use, is crucial for identifying DVST risk factors. Neuroimaging, specifically magnetic resonance venography (MRV) or computed tomography venography (CTV), is essential to confirm the diagnosis of DVST. Consider implementing a standardized diagnostic approach that incorporates these elements for accurate and timely diagnosis. Explore how incorporating a headache diary can aid in differentiating headache types.
Q: How do current anticoagulation guidelines inform best practice management of acute dural venous sinus thrombosis (DVST) in pregnant or postpartum patients, considering both maternal and fetal risks?
A: Managing acute dural venous sinus thrombosis (DVST) in pregnant or postpartum patients requires careful consideration of both maternal and fetal risks. Current guidelines generally recommend low molecular weight heparin (LMWH) as the preferred anticoagulant due to its safety profile in pregnancy, avoiding the teratogenic effects of warfarin. The duration of anticoagulation varies depending on the underlying cause of DVST and individual patient factors, but typically extends for at least 3-6 months. Close monitoring of coagulation parameters is essential throughout treatment. Management decisions should be made in consultation with a multidisciplinary team, including a neurologist, hematologist, and obstetrician, to ensure optimal maternal and fetal outcomes. Learn more about the specific considerations for LMWH dosing and monitoring during pregnancy and the postpartum period.
Patient presents with complaints suggestive of dural venous sinus thrombosis (DVST), also known as cerebral venous sinus thrombosis (CVST) or intracranial venous thrombosis. Symptoms include [Specific symptoms documented, e.g., headache, visual disturbances, seizures, focal neurological deficits, papilledema]. Onset of symptoms was [Onset timeframe]. Patient's past medical history includes [Relevant medical history, e.g., pregnancy, puerperium, oral contraceptive use, coagulopathy, malignancy, infection, dehydration]. Physical examination revealed [Specific findings, e.g., altered mental status, cranial nerve palsies]. Differential diagnosis includes migraine, meningitis, intracranial hemorrhage, and mass lesion. Imaging studies, including magnetic resonance venography (MRV) and computed tomography venography (CTV), were ordered to confirm the diagnosis and assess the extent of the thrombosis. Preliminary imaging findings suggest [Preliminary imaging findings, e.g., thrombosis in the superior sagittal sinus, transverse sinus]. Treatment plan includes anticoagulation therapy with [Specific anticoagulant, e.g., low molecular weight heparin, unfractionated heparin] to prevent clot propagation and reduce the risk of further neurological complications. Patient's neurological status will be closely monitored, and further investigations, including thrombophilia screening, will be considered to identify underlying causes. ICD-10 code I67.6 (Cerebral venous sinus thrombosis) is documented for billing and coding purposes. The patient's condition and treatment plan were discussed in detail, and they demonstrated understanding. Follow-up appointment scheduled for [date].